| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Alban John | Director | 4925 GREENVILLE AVENUE, SUITE 1310, DALLAS | /s/ Brad Mead | 19 Dec 2025 | 0001492597 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SRV | Common Stock | Purchase | $9,972 | +250 | +33% | $39.89 | 1,008 | 18 Dec 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Shares were acquired pursuant to the exercise of rights to acquire common shares in the Fund's transferrable rights offering, which expired on December 11, 2025, at the subscription price of $39.89. The number of common shares acquired was confirmed to exercising rights holders on December 18, 2025, following the pro-ration and allocation of shares pursuant to the over-subscription privilege. |
| F2 | Includes 8 shares of common stock acquired through an Automatic Dividend Reinvestment Plan (DRIP). |